ATP5PO and cancer: Many cancer models inhibit cell death in response to fluctuations of the PTP effectors, such as Ca2+ or Mg2+, reactive oxygen species (ROS), and matrix pH [32], or controlling the PTP association with its physiological inducer, the cyclophilin D (CyPD) [33,34,35] binding its OSCP subunit [34,36].